MedPath

Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer Patients

Completed
Conditions
Venous Thromboembolism
Registration Number
NCT06556953
Lead Sponsor
Haike Lei
Brief Summary

The aim of this study is to develop a machine learning model to accurately predict the risk of venous thromboembolism in patients with cervical cancer after surgery.

Detailed Description

Venous thromboembolism (VTE) is a common and life-threatening complication in patients with cervical cancer following surgery. The objective of this study is to develop a machine learning model with the potential to predict the risk of VTE in these patients postoperatively. We plan to employ partial dependence (PD) curves, breakdown (BD) curves, Ceteris-paribus (CP), and SHapley additive exPlanations (SHAP) values for a comprehensive analysis. The goal is to explore how different machine learning algorithms can be utilized as tools for personalized postoperative VTE risk assessment in cervical cancer patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1174
Inclusion Criteria
  • Confirmation of cervical cancer through pathological examination.
  • Receipt of surgical treatment for cervical cancer at Chongqing University Cancer Hospital in China.
  • Provision of comprehensive case information.
Exclusion Criteria
  • Patients under the age of 18.
  • History of VTE caused by other reasons before surgery.
  • Secondary cervical cancer or accompanying primary malignant tumor.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Whether the patient has developed VTE is determined based on the diagnostic criteria in the "Guidelines for the Prevention and Treatment of Tumor-Associated Venous Thromboembolism (2019 Edition)."December 31, 2023

The diagnosis of VTE primarily includes the diagnosis of DVT and PE. According to the guidelines, DVT is diagnosed using venous compression ultrasound or venography, while PE is diagnosed using CT pulmonary angiography (CTPA) or nuclear lung ventilation/perfusion imaging.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chongqing University Cancer Hospital

🇨🇳

Chongqing, Chongqing, China

© Copyright 2025. All Rights Reserved by MedPath